Anti‐interleukin‐6 signalling therapy rebalances the disrupted cytokine production of B cells from patients with active rheumatoid arthritis
Sarah Fleischer, Simon Fillatreau(Hôpital Necker-Enfants Malades), Stefanie Ries(Charité - Universitätsmedizin Berlin), Frédéric Cazals(Institut national de recherche en sciences et technologies du numérique), Gerd R Burmester(Charité - Universitätsmedizin Berlin), Thomas Dörner(German Rheumatism Research Centre), Alix Lhéritier, Ping Shen(Humboldt-Universität zu Berlin)
Cited by 15
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
B cells regulate autoimmunity by provision of IL-10
|Nature Immunology|2002|1.6k